Sponsors
Introduced September 11, 2025 by Robert Aderholt
The bill increases congressional oversight, certain targeted investments, and administrative transparency while simultaneously imposing broad programmatic prohibitions, funding rescissions, and regulatory limits that would shrink research scope, constrain agency flexibility, and reduce access to some health and social services.
Taxpayers, Congress, and state governments gain stronger transparency and congressional oversight because agencies and grantees must publish staffing/funding details, disclose federal shares, and provide quarterly reporting and operating plans.
Federal programs and beneficiaries benefit from greater ability to repurpose unexpended prior‑year balances and limited intra‑agency transfers, reducing short-term funding gaps for ongoing activities.
Scientists, hospitals, and students benefit from targeted investments in research infrastructure, medical countermeasure procurement flexibility, and new funding for program evaluations that aim to improve capacity and evidence on program effectiveness.
Researchers, patients, and public-health agencies face substantial limits because the bill bans or restricts a broad set of scientific activities (fetal tissue research, certain transgender‑related interventions, firearm‑policy research, gain‑of‑function work, embryo creation/destruction, and some foreign lab partnerships), reducing the ability to produce evidence and respond to health threats.
Families, children’s programs, and taxpayers may see real funding losses and increased fiscal uncertainty because the bill rescinds and reduces multiple contingency and program balances (including multi‑billion rescissions and smaller DOE rescissions).
People seeking reproductive health care and Title X providers will face reduced access because new certification/reporting rules and broad bans on abortion‑related funding restrict funding to many family‑planning providers and related services.
Based on analysis of 10 sections of legislative text.
Places pay caps for grantee-funded salaries, limits intra-agency transfers, bans procurement tied to forced child labor, revises Title X/Medicare/education and national service rules, and restricts advocacy uses of funds.
The legislation places new limits and conditions on FY2026 appropriations across Labor, HHS, and Education programs and on several domestic service programs. It caps salaries paid with covered federal funds at Executive Schedule Level II for many grantees and certain federal pay items, restricts intra-agency transfer authority (1% transfers with a 3% per-account cap and 15-day notice to Appropriations Committees), prohibits procurement of goods produced with forced or indentured child labor (as identified under existing rules), and imposes a range of program-specific rules for Title X, Medicare Advantage, higher education funding, Job Corps, and national service programs (including renaming AmeriCorps and changing matching/award rules). The bill also tightens transparency and anti‑advocacy rules for recipients (public disclosure of federal share and prohibitions on using funds for lobbying, propaganda, or promoting tax increases), authorizes limited reception/representation spending for certain officials, allows limited transfers of prior balances into current appropriations for the same purposes, and makes most appropriations available only for the current fiscal year unless explicitly stated otherwise.